Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Joan C Schertz"'
Autor:
Joan C Schertz, Hilary Worton
Publikováno v:
Expert Opinion on Drug Delivery. 15:435-442
Owing to the wide-ranging role nurses have in supporting patients undergoing fertility treatment, we recorded the learning/teaching expectations and experiences of nurses using a redesigned fertility pen injector.This was a multicentre, simulated-use
Publikováno v:
Expert Opinion on Drug Delivery. 13:1661-1669
The prefilled, multi-dose follitropin alfa (GONAL-f®) pen injector was redesigned based upon user feedback, to improve pen functionality. The dose information display was altered with the intention of improving readability and the dosing mechanism h
Publikováno v:
Drug Safety
Introduction Recombinant human luteinizing hormone (r-hLH) is used in a fixed-ratio combination with recombinant human follicle-stimulating hormone (r-hFSH) for the stimulation of follicular development. Objective The objective of this article was to
Publikováno v:
Lehert, P, Chin, W, Schertz, J, D'Hooghe, T, Alviggi, C & Humaidan, P 2018, ' Predicting live birth for poor ovarian responders : the PROsPeR concept ', Reproductive BioMedicine Online, vol. 37, no. 1, pp. 43-52 . https://doi.org/10.1016/j.rbmo.2018.03.013
RESEARCH QUESTION: A number of live-birth predictive models are available, and despite clinical interest these are rarely used owing to poor performance. In addition, no predictive models specifically for poor ovarian responders (POR) are available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1375cbdeefce8792d2ca9b7872efa64e
https://lirias.kuleuven.be/handle/123456789/624766
https://lirias.kuleuven.be/handle/123456789/624766
Autor:
Hilary Worton, Joan C Schertz
Publikováno v:
Expert opinion on drug delivery. 14(4)
We aimed to evaluate the overall impressions of learning and subsequent use of the redesigned GONAL-f® (follitropin alfa) pen injector by women with recent or current infertility requiring assisted reproductive technologies (ART) or in vitro fertili
Autor:
Salvatore Longobardi, W Chin, Joan C Schertz, Thomas D'Hooghe, D Rogoff, J Hubbard, Peter Humaidan
Publikováno v:
Humaidan, P, Chin, W, Rogoff, D, D'Hooghe, T, Longobardi, S, Hubbard, J, Schertz, J & ESPART Study Investigators 2017, ' Efficacy and safety of follitropin alfa/lutropin alfa in ART : a randomized controlled trial in poor ovarian responders ', Human reproduction (Oxford, England), vol. 32, no. 3, pp. 544-555 . https://doi.org/10.1093/humrep/dew360
Human Reproduction (Oxford, England)
Humaidan, P, Chin, W, Rogoff, D, D'Hooghe, T, Longobardi, S, Hubbard, J & Schertz, J 2017, ' Efficacy and safety of follitropin alfa/lutropin alfa in ART : a randomized controlled trial in poor ovarian responders ', Human reproduction (Oxford, England), vol. 32, no. 7, pp. 1537-1538 . https://doi.org/10.1093/humrep/dex208
Human Reproduction (Oxford, England)
Humaidan, P, Chin, W, Rogoff, D, D'Hooghe, T, Longobardi, S, Hubbard, J & Schertz, J 2017, ' Efficacy and safety of follitropin alfa/lutropin alfa in ART : a randomized controlled trial in poor ovarian responders ', Human reproduction (Oxford, England), vol. 32, no. 7, pp. 1537-1538 . https://doi.org/10.1093/humrep/dex208
STUDY QUESTION: How does the efficacy and safety of a fixed-ratio combination of recombinant human FSH plus recombinant human LH (follitropin alfa plus lutropin alfa; r-hFSH/r-hLH) compare with that of r-hFSH monotherapy for controlled ovarian stimul
Objectives: The prefilled, multidose, GONAL-f ® (follitropin alfa) pen injector was redesigned to improve ease of use and pen functionality. This usability engineering evaluation aimed to demonstrate that the redesigned pen injector could be used by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7cd06c8ae90b77b9abd16a3f55a64b2
Autor:
Michael Brodman, G. Witkin, Alan B. Copperman, Benjamin Sandler, Joan C. Schertz, K. Copperman
Publikováno v:
Journal of Women's Health. 16:1012-1016
To determine if length of patient-reported infertility prior to referral to a specialist is related to the likelihood that the patient will return to the referring physician for obstetrical care.A review of our medical record database identified 430
Publikováno v:
Current Medical Research and Opinion. 22:1981-1996
To evaluate patient satisfaction with the follitropin alfa prefilled pen (Gonal-f RFF Pen), compared with previously used injectable gonadotropins (vial/ampoules and syringe), in women undergoing ovulation induction (OI).Women aged 18-40 years underg
Patient and nurse evaluation of the improved follitropin alfa pen injector for infertility treatment
Publikováno v:
Fertility and Sterility. 106:e117-e118